PancEpistemeDx is a proprietary rapid diagnostic test designed specifically for pancreatic cancer patients. This innovative test evaluates tumor samples to predict how patients will respond to first-line chemotherapy treatments. By identifying responders, this test plays a crucial role in personalizing cancer care.